Weight Loss Medication Consumer Insights According to PwCs 2024 GLP-1 Trends and Impact survey, more than one in 10 Americans (around 14%) are currently taking a weight loss medication and nearly 35% have expressed interest in taking one
Natural GLP-1 is produced by the body, however, as we discussed earlier, it has a very short lifespan, and patients with T2D and other metabolic disorders can experience reduced secretion of the hormone or reduced sensitivity to it
Genomic DNA hypomethylation, a characteristic of most cancers, is present in peripheral leukocytes of individuals who are homozygous for the C677T polymorphism in the methylenetetrahydrofolate reductase gene
(6) Tucker M, Keely A, Park JY, Rosenfeld M, Wezeman J, Mangalindan R, Ratner D, Ladiges W
2016;34(7):293.e1-e10